Pregled bibliografske jedinice broj: 1259753
Case Report: Amphotericin B and Mefloquine as a Salvage Treatment of Alveolar Echinococcosis
Case Report: Amphotericin B and Mefloquine as a Salvage Treatment of Alveolar Echinococcosis // The American Journal of Tropical Medicine and Hygiene, 108 (2023), 3; 581-583 doi:10.4269/ajtmh.22-0465 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1259753 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Case Report: Amphotericin B and Mefloquine as a
Salvage Treatment of Alveolar Echinococcosis
Autori
Jeličić, Karlo ; Papić, Neven ; Višković, Klaudija ; Vince, Adriana
Izvornik
The American Journal of Tropical Medicine and Hygiene (0002-9637) 108
(2023), 3;
581-583
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Amphotericin B ; Mefloquine ; alveolar echinococcosis
Sažetak
Alveolar echinococcosis is an emerging zoonotic disease caused by the parasite Echinococcus multilocularis. Most patients are diagnosed at a late stage, when lifelong treatment with benzimidazoles is required to stop disease progression. However, for patients who do not tolerate benzimidazole therapy, there are no alternatives. Here, we present a patient with advanced alveolar echinococcosis who was successfully treated with amphotericin B deoxycholate and mefloquine as a rescue therapy after he developed albendazole intolerance.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
